CHIA-MIN LIUYI-WEN LIAOCHUAN-HANG YUTAI-CHEN LINPO-YU YANGCHENG-CHIA YU2026-10-162026-10-162019-07-01Pure ID: 15409827Pure UUID: fb445d45-f868-4bea-8eb7-a024de892fae10.1016/j.jfma.2019.02.014https://www.scopus.com/pages/publications/85063393961https://scholars.csmu.edu.tw/handle/123456789/32393Background/purpose: Oral submucous fibrosis (OSF) is a precancerous condition of oral cancer with a complex etiology. Our previous work has demonstrated that non-coding RNA miR-1246 contributes to the cancer stemness of oral cancer. In the current study, we sought to investigate the effect of the inhibition of miR-1246 on the oral fibrogenesis. Methods: The expression levels of miR-1246 in OSF tissues and fibrotic buccal mucosal fibroblasts (fBMFs) were examined by qRT-PCR. Collagen gel contraction and migration assays were conducted to evaluate the myofibroblast activities. The relationship between miR-1246 and type I collagen was assessed and the protein expression of type I collagen was determined by Western blot. Results: MiR-1246 expression was upregulated in both OSF specimen and fBMFs compared to the normal counterparts. Inhibition of miR-1246 successfully suppressed the myofibroblast activities, including collagen gel contractility and migration capacity. Moreover, the expression of miR-1246 was positively correlated with type I collagen and the expression of type I collagen was abrogated by repression of miR-1246. Conclusion: MiR-1246 is not only critical to the maintenance of oral stemness but also important to the activation of myofibroblasts. Our results showed that miR-1246 is positively associated with the type I collagen, which may be a downstream effector of miR-1246 and responsible for the fibrosis effect on fBMFs.6enmiR-1246 as a therapeutic target in oral submucosa fibrosis pathogenesisjournal article